Volume 361, Issue 9352, Pages (January 2003)

Slides:

Advertisements

Similar presentations

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Advertisements

Volume 379, Issue 9824, Pages (April 2012)

Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled.

Volume 384, Issue 9961, Pages (December 2014)

Volume 352, Issue 9131, Pages (September 1998)

Pathogenesis of urinary tract infections with normal female anatomy

Volume 357, Issue 9273, Pages (June 2001)

Volume 387, Issue 10022, Pages (March 2016)

Volume 357, Issue 9257, Pages (March 2001)

Volume 370, Issue 9601, Pages (November 2007)

Volume 359, Issue 9322, Pages (June 2002)

Pharmacogenetics and future drug development and delivery

Volume 349, Issue 9057, Pages (April 1997)

Volume 12, Issue 11, Pages (October 2011)

Volume 376, Issue 9734, Pages (July 2010)

Long-term effects of hormone replacement therapy

Isolated Systolic Hypertension: An Update After SPRINT

Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD.

Volume 387, Issue 10022, Pages (March 2016)

Understanding EMPA-REG OUTCOME

Combination therapy with ACE inhibitors and angiotensin II receptor blockers in chronic renal disease: New therapeutic world beyond blood pressure reduction

Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial

Abdominal lipohypertrophy without insulin injection

Volume 355, Issue 9204, Pages (February 2000)

Volume 371, Issue 9611, Pages (February 2008)

Volume 376, Issue 9734, Pages (July 2010)

Thinking Beyond New Clinical Guidelines: Update in Hypertension

Physical activity and prevention of type 2 diabetes

Long-term effects of hormone replacement therapy

Volume 366, Issue 9486, Pages (August 2005)

A twin with Cushing's disease

Step Care Therapy for Hypertension in Diabetic Patients

Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled.

Volume 373, Issue 9677, Pages (May 2009)

Aspirin in the prevention of cancer – Author's reply

Membranous nephropathy: When and how to treat

Correction to Lancet Diabetes Endocrinol 2015; 3: 263–74

Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes Mellitus George L. Bakris, MD Mayo Clinic.

Non-surgical treatment of diabetic foot osteomyelitis

Gene therapy—where are we?

Non-uraemic calciphylaxis with acral necrosis

Volume 378, Issue 9786, Pages (July 2011)

Volume 372, Issue 9642, Pages (September 2008)

Volume 9, Issue 10, Pages (October 2008)

Incident diabetes in clinical trials of antihypertensive drugs

Volume 375, Issue 9732, Pages (June 2010)

Resuscitation at birth and cognition at 8 years of age: a cohort study

Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016 Murray Epstein, MD, Daniel A. Duprez,

Bruce Neal, Fiona Turnbull The Lancet

Correction to Lancet Diabetes Endocrinol 2015; 3: 263–74

Volume 372, Issue 9647, Pages (October 2008)

Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial

Volume 371, Issue 9627, Pages (May 2008)

Volume 378, Issue 9786, Pages (July 2011)

C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study Heart Protection.

Volume 377, Issue 9771, Pages (March 2011)

Department of Error The Lancet Volume 369, Issue 9564, (March 2007)

Volume 373, Issue 9668, Pages (March 2009)

Diagnosis of tuberculous meningitis with invasive pulmonary sampling

Volume 375, Issue 9714, Pages (February 2010)

Volume 373, Issue 9668, Pages (March 2009)

Muh Geot Wong, Vlado Perkovic The Lancet Diabetes & Endocrinology

Volume 67, Issue 1, Pages (January 2005)

Isolated Systolic Hypertension: An Update After SPRINT

Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors Barry M. Brenner, Joann Zagrobelny

Carmine Zoccali, Francesca Mallamaci Kidney International

Volume 73, Issue 5, Pages (March 2008)

ECASS-II: intravenous alteplase in acute ischaemic stroke

Clinic attendance and disengagement of young adults with type 1 diabetes after transition of care from paediatric to adult services (TrACeD): a randomised,

Volume 371, Issue 9611, Pages (February 2008)

Presentation transcript:

Volume 361, Issue 9352, Pages 117-124 (January 2003) RETRACTED: Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial Dr Naoyuki Nakao, MD, Ashio Yoshimura, MD, Hiroyuki Morita, MD, Masyuki Takada, MD, Tsuguo Kayano, MD, Prof Terukuni Ideura, MD The Lancet Volume 361, Issue 9352, Pages 117-124 (January 2003) DOI: 10.1016/S0140-6736(03)12229-5 Copyright © 2003 Elsevier Ltd Terms and Conditions

Figure 1 Trial profile The Lancet 2003 361, 117-124DOI: (10.1016/S0140-6736(03)12229-5) Copyright © 2003 Elsevier Ltd Terms and Conditions

Figure 2 Proportion of patients reaching endpoint The Lancet 2003 361, 117-124DOI: (10.1016/S0140-6736(03)12229-5) Copyright © 2003 Elsevier Ltd Terms and Conditions

Figure 3 Blood pressure by treatment group The Lancet 2003 361, 117-124DOI: (10.1016/S0140-6736(03)12229-5) Copyright © 2003 Elsevier Ltd Terms and Conditions

Figure 4 Median urinary protein excretion by treatment group The Lancet 2003 361, 117-124DOI: (10.1016/S0140-6736(03)12229-5) Copyright © 2003 Elsevier Ltd Terms and Conditions